ERGOMEDS's approach to clinical
research ensures effective patient
recruitment reducing time and cost
of clinical trials.

Our expertise and depth of experience in the clinical development process complements the drug discovery and development capabilities of our partners.

ERGOMED has a dual business model offering standard clinical trial management contracts and also co-development partnerships to share the risk and rewards of clinical development.

October, 30, 2007 - ERGOMED locates regional headquarters at DuBiotech in Dubai. [read more]

October, 22, 2007 - ERGOMED opens new facility in Russia. Dr Sergei Drapkin appointed as Managing Director of Russian office. [read more]

September, 10, 2007 - CeNeS and ERGOMED Report Start of Recruitment for Phase II trial of CNS 5161 in cancer pain. [read more]

[more News]

16th BioPartnering, London
October 12. - 14. 2008

BioEurope 2008, Mannheim
November 17. - 19. 2008

ASH, Orlando
December 9. - 12. 2008

[more Events]